These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26134269)

  • 1. Reducing the impact of influenza-associated secondary pneumococcal infections.
    Mifsud EJ; Tan AC; Short KR; Brown LE; Chua BY; Jackson DC
    Immunol Cell Biol; 2016 Jan; 94(1):101-8. PubMed ID: 26134269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.
    Mifsud EJ; Tan AC; Reading PC; Jackson DC
    Immunol Cell Biol; 2016 Feb; 94(2):169-76. PubMed ID: 26272554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.
    Metzger DW; Furuya Y; Salmon SL; Roberts S; Sun K
    J Infect Dis; 2015 Aug; 212(3):445-52. PubMed ID: 25649173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
    Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
    J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice.
    Tan AC; Mifsud EJ; Zeng W; Edenborough K; McVernon J; Brown LE; Jackson DC
    Mol Pharm; 2012 Sep; 9(9):2710-8. PubMed ID: 22823162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Immunization With an Attenuated pep27 Mutant Provides Protection From Influenza Virus and Secondary Pneumococcal Infections.
    Seon SH; Choi JA; Yang E; Pyo S; Song MK; Rhee DK
    J Infect Dis; 2018 Jan; 217(4):637-640. PubMed ID: 29145619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfection.
    Ellis GT; Davidson S; Crotta S; Branzk N; Papayannopoulos V; Wack A
    EMBO Rep; 2015 Sep; 16(9):1203-18. PubMed ID: 26265006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.
    Sharma-Chawla N; Sender V; Kershaw O; Gruber AD; Volckmar J; Henriques-Normark B; Stegemann-Koniszewski S; Bruder D
    Infect Immun; 2016 Dec; 84(12):3445-3457. PubMed ID: 27647871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 2 does not contribute to host response during postinfluenza pneumococcal pneumonia.
    Dessing MC; van der Sluijs KF; Florquin S; Akira S; van der Poll T
    Am J Respir Cell Mol Biol; 2007 May; 36(5):609-14. PubMed ID: 17170383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.
    Ghoneim HE; Thomas PG; McCullers JA
    J Immunol; 2013 Aug; 191(3):1250-9. PubMed ID: 23804714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin Decreases Susceptibility to
    Wang X; Yuan J; Wang H; Gan N; Zhang Q; Liu B; Wang J; Shu Z; Rao L; Gou X; Zhang H; Yin Y; Zhang X
    J Immunol; 2019 Oct; 203(8):2171-2182. PubMed ID: 31519865
    [No Abstract]   [Full Text] [Related]  

  • 14. Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae.
    Tanaka A; Nakamura S; Seki M; Fukudome K; Iwanaga N; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Clin Vaccine Immunol; 2013 Jul; 20(7):977-85. PubMed ID: 23637040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice.
    Karlsson EA; Meliopoulos VA; van de Velde NC; van de Velde LA; Mann B; Gao G; Rosch J; Tuomanen E; McCullers J; Vogel P; Schultz-Cherry S
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.
    Pejoski D; Zeng W; Rockman S; Brown LE; Jackson DC
    Immunol Cell Biol; 2010 Jul; 88(5):605-11. PubMed ID: 20177411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate.
    Zeng W; Tan AC; Horrocks K; Jackson DC
    Vaccine; 2015 Jul; 33(30):3526-32. PubMed ID: 26049002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.
    Damjanovic D; Lai R; Jeyanathan M; Hogaboam CM; Xing Z
    Am J Pathol; 2013 Sep; 183(3):868-80. PubMed ID: 23831294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.